REACH+ 2.0 for Anorexia

(REACH+ Trial)

JS
Overseen ByJoanna Steinglass, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: New York State Psychiatric Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after structured treatment. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.

Are You a Good Fit for This Trial?

This trial is for people who have been treated for anorexia nervosa and are at risk of relapse. Participants should be in remission after structured treatment but may still have low bone density (osteopenia).

Inclusion Criteria

I have been diagnosed with Anorexia Nervosa or Atypical Anorexia Nervosa.
Has a medical treatment provider who can be made aware of study participation
Access to internet-connected device with videoconferencing capability
See 4 more

Exclusion Criteria

Current substance use disorder or other co-occurring psychiatric diagnoses requiring specialized treatment
Pregnant
High risk of suicide
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • Relapse Prevention and Changing Habits (REACH+ 2.0)

Trial Overview

The study is testing a program called REACH+ 2.0, which aims to prevent relapse in people recovering from anorexia by helping them maintain healthy habits and avoid weight loss.

How Is the Trial Designed?

24

Treatment groups

Experimental Treatment

Group I: Talk, Change, Values, Short-Term Food LogsExperimental Treatment1 Intervention
Group II: Talk, Change, Values, No Food LogsExperimental Treatment1 Intervention
Group III: Talk, Change, Values, Long-Term Food LogsExperimental Treatment1 Intervention
Group IV: Talk, Change, Narrative, Short-Term Food LogsExperimental Treatment1 Intervention
Group V: Talk, Change, Narrative, No Food LogsExperimental Treatment1 Intervention
Group VI: Talk, Change, Narrative, Long-Term Food LogsExperimental Treatment1 Intervention
Group VII: Talk, Accept, Values, Short-Term Food LogsExperimental Treatment1 Intervention
Group VIII: Talk, Accept, Values, No Food LogsExperimental Treatment1 Intervention
Group IX: Talk, Accept, Values, Long-Term Food LogsExperimental Treatment1 Intervention
Group X: Talk, Accept, Narrative, Short-Term Food LogsExperimental Treatment1 Intervention
Group XI: Talk, Accept, Narrative, No Food LogsExperimental Treatment1 Intervention
Group XII: Talk, Accept, Narrative, Long-Term Food LogsExperimental Treatment1 Intervention
Group XIII: Do, Change, Values, Short-Term Food LogsExperimental Treatment1 Intervention
Group XIV: Do, Change, Values, No Food LogsExperimental Treatment1 Intervention
Group XV: Do, Change, Values, Long-Term Food LogsExperimental Treatment1 Intervention
Group XVI: Do, Change, Narrative, Short-Term Food LogsExperimental Treatment1 Intervention
Group XVII: Do, Change, Narrative, No Food LogsExperimental Treatment1 Intervention
Group XVIII: Do, Change, Narrative, Long-Term Food LogsExperimental Treatment1 Intervention
Group XIX: Do, Accept, Values, Short-Term Food LogsExperimental Treatment1 Intervention
Group XX: Do, Accept, Values, No Food LogsExperimental Treatment1 Intervention
Group XXI: Do, Accept, Values, Long-Term Food LogsExperimental Treatment1 Intervention
Group XXII: Do, Accept, Narrative, Short-Term Food LogsExperimental Treatment1 Intervention
Group XXIII: Do, Accept, Narrative, No Food LogsExperimental Treatment1 Intervention
Group XXIV: Do, Accept, Narrative, Long-Term Food LogsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York State Psychiatric Institute

Lead Sponsor

Trials
481
Recruited
154,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

The University of Tennessee, Knoxville

Collaborator

Trials
93
Recruited
19,500+